The objective of this study was to compare prospectively the efficacy of fixed burst pacing
with that of decremental hurst pacing in terminating VT. Forty‐four patients with inducible …

Recurrent, drug-refractory sustained tachycardias present a difficult management problem.
After invasive electrophysiologic study and extensive antiarrhythmic drug testing, a …

This report describes the Jong‐term follow‐up of two patients who received implantable
automatic burst tachycardia‐terminating ventricular pacemakers for the treatment of drug …

Between 1979 and 1984 the Cybertach‐60,(Intermedics, Inc. Model 262–01), a
programmable, automatic antitachycardia pacemaker was implanted in 11 patients who had …

This study was undertaken to determine the safety and efficacy of three different pacing
modalities on the termination of ventricular tachyarrhythmias. Thirty‐two patients were …

SULKE, AN, ET AL.: Supraventricular Tachycardia Control with Tachylog 11: Long‐Term
Follow‐Up. Ten patients aged 16–63 years (mean 36.3) had the Siemens P56T “Tachylog II” …

Focuses on the clinical utility of implantable multiprogrammable automatic antitachycardia
pulse generator as a external device. Potential of automatic antitachycardia pulse generator …

This report describes the multicenter experience of the Tachylog antitachycardia pacemaker
(Siemens-Elema) in the treatment of drug-refractory, recurrent supraventricular arrhythmias …

Chronic overdrive suppression pacing has been suggested as an effective adjunctive
method for reducing the incidence of cardiac tachyarrhythmias. Documentation of …

Different implantable systems for electrical treatment of ventricular arrhythmias are available.
Information about mode of termination of ventricular tachycardia (VT) helps to select the …